Cancer Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
ImmunoCellular Therapeutics, Ltd.
Clinical Data from Trial of ImmunoCellular Therapeutics’ Cancer Vaccine ICT-107 to Be Presented at ASCO 2009 Annual Meeting
June 9th, 2009
ImmunoCellular Therapeutics, Ltd. (OTCBB: IMUC) (IMUC), a biotechnology company, announced that clinical data from the company’s Phase 1 trial of cancer vaccine ICT-107, will be presented at the American Society of Clinical Oncology (ASCO) 2009 Annual Meeting taking place May 29 through June 2, 2009 in Orlando, Florida. Following are the presentation details: Abstract #2032: “A phase I trial of tumor associated antigen-pulsed dendritic cell immunotherapy for patients with brain stem glioma and glioblastoma.” Poster to be presented in the Central Nervous System Tumors session on May 31, 2009, 8:00 a.m. to 12:00 p.m. EDT (Level 2, West Hall C) by Surasak Phuphanich, MD,...
Source: Cancer Weekly (2009-06-09)
|
